Comparison of the human tumor metastasis gene expression level in neuroblastoma patients with MYCN amplification and 2p gain: Pilot study

- The differences in the expression level of 92 genes engaged in human tumors metastasis pathways between two groups of neuroblastoma patients: MYCN amplification vs. 2p gain, were reported.
- It improves the knowledge about the role of 2p gain and indicates two potentially important genetic factors in the pathogenesis of neuroblastoma tumor without MYCN amplification.